Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000895527-21-000037
Filing Date
2021-10-28
Accepted
2021-10-28 13:13:34
Documents
1
Effectiveness Date
2021-10-28
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 4826
  Complete submission text file 0000895527-21-000037.txt   5899
Mailing Address 2450 HOLCOMBE BLVD SUITE XI I.218 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE XI I.218 HOUSTON TX 77021 (713) 357-1045
Vyripharm Enterprises, Inc. (Filer) CIK: 0001887609 (see all company filings)

IRS No.: 851718177 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-418970 | Film No.: 211356740